Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-11 · accession 0001628280-26-017447 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | 2026-03-11 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | S - Sale | $60.46 | -16.5K | 80.0K | -17% | -$996.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-11 | S | D | 16,486 | $60.46 | 79,953 | D | — | — | (F1) The price in column 4 is the weighted average price. The purchase price actually received ranged from $60.39 to $60.62. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price |